INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,279,377 | -12.5% | 40,461 | +12.8% | 0.07% | -9.0% |
| Q2 2023 | $1,462,738 | +8.6% | 35,869 | -0.7% | 0.08% | -6.0% |
| Q1 2023 | $1,346,863 | +234.7% | 36,138 | +213.3% | 0.08% | +219.2% |
| Q4 2022 | $402,456 | -28.6% | 11,535 | +14.5% | 0.03% | -36.6% |
| Q3 2022 | $564,000 | +12.8% | 10,077 | +4.3% | 0.04% | +28.1% |
| Q2 2022 | $500,000 | -35.6% | 9,665 | -9.6% | 0.03% | -3.0% |
| Q1 2022 | $777,000 | -44.7% | 10,686 | -10.0% | 0.03% | -28.3% |
| Q4 2021 | $1,404,000 | -20.1% | 11,877 | -9.3% | 0.05% | -22.0% |
| Q3 2021 | $1,757,000 | +479.9% | 13,098 | +598.2% | 0.06% | +490.0% |
| Q2 2021 | $303,000 | – | 1,876 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
| Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
| MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
| Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
| ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
| Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
| Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
| Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |